The Society for Immunotherapy of Cancer (SITC) hosted Session 208c during the 38th Annual Meeting & Pre-Conference Programs on Saturday, November 4, 2023. Available here are the presentation slides and video from “Session 208c: Manufacturing” as permitted by presenters.
Michal Besser, PhD – Davidoff Center, Rabin Medical Center
Isabelle Riviere, PhD – Takeda
In this session, you will be informed about the most recent advancements in the manufacturing of cells and genetic engineering platforms for cell therapy clinical applications. The presentation will cover topics including automation, as well as the effects of manufacturing processes on the functionality and fitness of T-cells. The session will also delve into aspects of retroviral and lentiviral vectors manufacturing, as well as alternative approaches such as gene editing. Additionally, the production and engineering of NK cells and macrophages for clinical use will be discussed.
To view the entire program schedule (including presenter permission to post) please click here.
SITC 2023 Annual Meeting: Saturday, November 401:26:52